Table 3.

Univariate and multivariate associations between clinical characteristics and first day MBL concentrations.

		Univariate analysis				Multivariate analysis
Clinical characteristics	n	MBL (µg/ml) Median (IQR)	R	P-value	B	95% CI	R2	P-value
Gestational age	84		0·14	0·22	0·09	0·03–0·14	0·49	0·004
Birth weight	84		0·06	0·62
MBL genotype group*				< 0·001			0·39
High	41	1·64 (0·98–2·00)			1	; –		–
Medium	15	0·35 (0·11–0·56)			−1·22	−1·82–0·63		< 0·001
Low	10	0·10 (0·05–0·33)			−1·92	−2·56–1·28		< 0·001
Pregnancy-related disease				0·21
Yes	22	0·66 (0·26–1·56)
No	62	1·12 (0·38–1·94)
Mode of delivery				0·43
Vaginal	33	0·77 (0·26–1·89)
Caesarean	51	1·10 (0·43–1·89)
Maternal fever				0·10
Yes	24	0·68 (0·16–1·67)
No	60	1·12 (0·44–1·97)
PROM				0·43
Yes	23	1·15 (0·47–1·97)
No	61	0·77 (0·32–1·89)
Antenatal steroid exposure				0·27
Yes	37	0·84 (0·37–1·64)
No	47	0·99 (0·33–1·94)
Fetal distress				0·29
Yes	42	0·79 (0·31–1·56)
No	42	1·54 (0·42–1·93)

^*MBL2 genotypes of 15 neonates were missing. PROM, prolonged rupture of membranes; IQR, interquartile range; R, Spearman’s rank correlation coefficient; B, regression coefficient; 95% CI, 95% confidence interval

²R², Adjusted cumulative explained variance.